{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:46:20Z","timestamp":1791225980626,"version":"4.1.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/aci.0b013e328354395d","type":"journal-article","created":{"date-parts":[[2012,7,4]],"date-time":"2012-07-04T22:39:26Z","timestamp":1341441566000},"page":"383-388","source":"Crossref","is-referenced-by-count":18,"title":["Safety of influenza vaccines"],"prefix":"10.1097","volume":"12","author":[{"given":"John M.","family":"Kelso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","first-page":"1057","article-title":"Estimates of deaths associated with seasonal influenza: United States, 1976-2007.","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJMoa0808652","article-title":"Comparative efficacy of inactivated and live attenuated influenza vaccines.","volume":"361","author":"Monto","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-9-20210128","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-9-20210128","first-page":"1128","article-title":"Vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0022-3476(98)70101-5","article-title":"Safe administration of influenza vaccine to patients with egg allergy.","volume":"133","author":"James","year":"1998","journal-title":"J Pediatr"},{"key":"R6-9-20210128","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1542\/peds.2009-2512","article-title":"Safety of influenza vaccine administration in egg-allergic patients.","volume":"125","author":"Chung","year":"2010","journal-title":"Pediatrics"},{"key":"R7-9-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jaci.2010.05.037","article-title":"Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine.","volume":"126","author":"Gagnon","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.anai.2010.08.015","article-title":"The safety of the H1N1 influenza A vaccine in egg allergic individuals.","volume":"105","author":"Greenhawt","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R9-9-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaci.2010.10.005","article-title":"Higher-ovalbumin-content influenza vaccines are well tolerated in children with egg allergy.","volume":"127","author":"Owens","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaci.2011.02.013","article-title":"Single-dose influenza vaccination of patients with egg allergy in a multicenter study.","volume":"128","author":"Webb","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.anai.2011.01.024","article-title":"Safe administration of seasonal influenza vaccine to children with egg allergy of all severities.","volume":"106","author":"Howe","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1081-1206(10)60350-X","article-title":"Adverse reactions to vaccines.","volume":"103","author":"Kelso","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jaci.2010.03.009","article-title":"Ovalbumin content of influenza vaccines.","volume":"125","author":"Li","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jaci.2011.02.003","article-title":"Ovalbumin content of 2010-2011 influenza vaccines.","volume":"127","author":"McKinney","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1542\/peds.2011-2295","article-title":"Recommendations for prevention and control of influenza in children, 2011-2012.","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","article-title":"Guillain-Barre syndrome after exposure to influenza virus.","volume":"10","author":"Lehmann","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/594124","article-title":"Guillain-Barre syndrome and influenza virus infection.","volume":"48","author":"Sivadon-Tardy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R19-9-20210128","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1016\/j.vaccine.2007.03.053","article-title":"Guillain-Barre syndrome after vaccination in United States a report from the CDCFDA Vaccine Adverse Event Reporting System.","volume":"25","author":"Souayah","year":"2007","journal-title":"Vaccine"},{"key":"R20-9-20210128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1201.051007","article-title":"Reflections on the 1976 swine flu vaccination program.","volume":"12","author":"Sencer","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977.","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"R22-9-20210128","first-page":"657","article-title":"Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R24-9-20210128","first-page":"1","article-title":"Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"59","author":"Fiore","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R25-9-20210128","first-page":"1529","article-title":"N Engl J M","volume":"345","year":"2001","journal-title":"ed"},{"key":"R26-9-20210128","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.inf.0000109392.96411.4f","article-title":"Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents.","volume":"23","author":"Bergen","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R27-9-20210128","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1542\/peds.2004-2258","article-title":"Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.","volume":"116","author":"Piedra","year":"2005","journal-title":"Pediatrics"},{"key":"R28-9-20210128","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.inf.0000237797.14283.cf","article-title":"Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.","volume":"25","author":"Fleming","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R29-9-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/INF.0b013e3181660c2e","article-title":"Safety of the intranasal, trivalent, live attenuated influenza vaccine (LAIV) in children with intermittent wheezing in an open-label field trial.","volume":"27","author":"Gaglani","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R30-9-20210128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R31-9-20210128","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00467-010-1729-1","article-title":"Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study.","volume":"26","author":"Nailescu","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"R32-9-20210128","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbmt.2010.10.002","article-title":"Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.","volume":"17","author":"Issa","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R33-9-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jpeds.2010.10.034","article-title":"Acceptance and adverse events of the 2009 H1N1 vaccination in immunosuppressed pediatric liver transplant recipients.","volume":"158","author":"Goldschmidt","year":"2011","journal-title":"J Pediatr"},{"key":"R34-9-20210128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jcv.2010.11.013","article-title":"Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.","volume":"50","author":"Mackay","year":"2011","journal-title":"J Clin Virol"},{"key":"R35-9-20210128","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1111\/j.1432-2277.2010.01193.x","article-title":"Pancreas rejection after pandemic influenzavirus A(H1N1) vaccination or infection: a report of two cases.","volume":"24","author":"Fabio","year":"2011","journal-title":"Transpl Int"},{"key":"R36-9-20210128","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/cid\/ciq004","article-title":"Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety.","volume":"52","author":"Madhi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R37-9-20210128","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.vaccine.2011.04.113","article-title":"A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years.","volume":"29","author":"Tennis","year":"2011","journal-title":"Vaccine"},{"key":"R38-9-20210128","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R39-9-20210128","first-page":"989","article-title":"Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010-11.","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e328354395d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T16:50:52Z","timestamp":1636563052000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201208000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e328354395d","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}